Nucleai

Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology, and Mayo Clinic BioPharma Diagnostics are…

Nucleai, an AI-powered spatial biology leader, announced that Dr. Julian Adams has joined its scientific advisory board. Dr. Adams brings his more…

Nucleai, a leader in AI-powered spatial biology, announced the expansion of its spatial biology platform to include a new generation of multiplex…

Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, announced the appointment of…

Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, and Sirona Dx, a leading…

Nucleai, a leader in Artificial Intelligence (AI) powered spatial analysis for pathology, and Ultivue, an industry leader in multiplexing tools for…

Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its…

Nucleai, a global provider in pathology-based biomarker discovery, and Debiopharm, a Swiss-based biopharmaceutical company specializing in drug…

How did you start in this space? What inspired you to work in AI for Healthcare? I knew little to nothing about the field of pathology until my…

Collaboration Marks the First Time a Us Lab Will Offer Advanced AI-Based Biopsy Analysis as a Quality Assurance Service Enhancement to Customers…